AXGN - Company ID 0000805928
The table below shows Axogen, Inc.'s income statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q3 2026 | Q2 2026 | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Revenue | $75.83M | $69.73M | $61.46M | $60.08M | $56.66M | $48.56M |
| Cost of revenue | $19.10M | $19.06M | $15.27M | $14.09M | $14.64M | $13.63M |
| Gross profit | $56.73M | $50.67M | $46.19M | $45.99M | $42.02M | $34.93M |
| R&D | $8.95M | $8.59M | $7.52M | $7.57M | $6.85M | $6.09M |
Axogen, Inc. reported annual revenue of $225.21M for fiscal year 2025. That is up 20.2% from $187.34M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $41.11M (FY 2016) to $225.21M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A | $16.46M | $13.41M | $12.87M | $10.84M | $9.69M | $9.46M |
| Operating income | $955.00K | -$2.16M | -$2.83M | $1.91M | $1.67M | -$1.66M |
| Income tax | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $2.33M | -$1.52M | -$19.58M | $708.00K | $579.00K | -$3.83M |
| EPS (diluted) | $0.04 | -$0.03 | -$0.38 | $0.01 | $0.01 | -$0.08 |